INmune Bio, Inc. (INMB) Ownership

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$1.16
Day's range
$1.39

INmune Bio Inc Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 1.21 M $1.89 M   2.13% 4.56%
VANGUARD GROUP INC 01/29/2026 957.85 K $1.49 M   9.31% 3.60%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 441.65 K $689.17 K   -5.92% 1.66%
STATE STREET CORP 02/13/2026 347.26 K $541.72 K   22.35% 1.31%
DAUNTLESS INVESTMENT GROUP, LLC 02/17/2026 304.92 K $475.68 K   100.00% 1.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 250.91 K $391.42 K   59.86% 0.94%
RAYMOND JAMES FINANCIAL INC 02/18/2026 210.68 K $328.66 K   -21.52% 0.79%
NORTHERN TRUST CORP 02/17/2026 175.65 K $274.01 K   -7.12% 0.66%
MORGAN STANLEY 02/13/2026 122.51 K $191.12 K   61.82% 0.46%
WESTSIDE INVESTMENT MANAGEMENT, INC. 01/23/2026 108.95 K $169.96 K   5.32% 0.41%
XTX TOPCO LTD 02/17/2026 68.87 K $107.43 K   41.28% 0.26%
UBS GROUP AG 01/29/2026 60.80 K $94.85 K   -60.90% 0.23%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 59.00 K $92.04 K   -62.08% 0.22%
BANK OF NEW YORK MELLON CORP 02/10/2026 58.52 K $91.29 K   -2.22% 0.22%
GOLDMAN SACHS GROUP INC 03/25/2026 56.48 K $88.10 K   269.03% 0.21%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 50.25 K $78.39 K   20.15% 0.19%
CITADEL ADVISORS LLC 02/17/2026 45.70 K $71.29 K   -77.22% 0.17%
LAIRD NORTON TRUST COMPANY, LLC 02/17/2026 45.00 K $70.20 K   80.00% 0.17%
JAIN GLOBAL LLC 02/17/2026 42.05 K $65.60 K   100.00% 0.16%
JPMORGAN CHASE & CO 02/11/2026 41.37 K $64.53 K   -28.33% 0.16%
BUCKINGHAM STRATEGIC PARTNERS 02/11/2026 41.10 K $64.11 K   0.36% 0.15%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 38.90 K $60.68 K   -59.56% 0.15%
PNC FINANCIAL SERVICES GROUP, INC. 02/06/2026 37.81 K $58.98 K   -1.52% 0.14%
BARCLAYS PLC 02/13/2026 32.02 K $49.95 K   6.71% 0.12%
RHUMBLINE ADVISERS 02/13/2026 27.53 K $42.94 K   21.54% 0.10%
BANK OF MONTREAL /CAN/ 02/12/2026 25.99 K $40.54 K   100.00% 0.10%
TWO SIGMA SECURITIES, LLC 02/17/2026 25.36 K $39.57 K   100.00% 0.10%
WELLS FARGO & COMPANY/MN 02/13/2026 24.86 K $38.78 K   78.99% 0.09%
JANE STREET GROUP, LLC 02/12/2026 22.96 K $35.81 K   -53.69% 0.09%
ALLIANCEBERNSTEIN L.P. 02/17/2026 21.95 K $34.24 K   0.00% 0.08%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 20.52 K $32.01 K   1.05% 0.08%
VIRTU FINANCIAL LLC 02/23/2026 20.39 K $32.00 K   100.00% 0.08%
BANK OF AMERICA CORP /DE/ 02/17/2026 18.54 K $28.93 K   82.01% 0.07%
QUADRATURE CAPITAL LTD 02/17/2026 16.96 K $26.46 K   100.00% 0.06%
LMR PARTNERS LLP 02/17/2026 16.60 K $25.90 K   0.00% 0.06%
NUVEEN, LLC 02/12/2026 16.52 K $25.77 K   0.00% 0.06%
FMR LLC 02/17/2026 14.10 K $21.99 K   344.56% 0.05%
CARY STREET PARTNERS FINANCIAL LLC 02/09/2026 13.92 K $21.71 K   0.00% 0.05%
SQUAREPOINT OPS LLC 02/13/2026 13.30 K $20.75 K   -8.68% 0.05%
DIMENSIONAL FUND ADVISORS LP 02/12/2026 10.58 K $16.51 K   0.00% 0.04%
BEACON POINTE ADVISORS, LLC 02/18/2026 10.37 K $16.18 K   0.00% 0.04%
MARINER, LLC 02/13/2026 10.25 K $15.99 K   -16.88% 0.04%
DAVENPORT & CO LLC 01/12/2026 10.00 K $15.60 K   0.00% 0.04%
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. 02/17/2026 9.97 K $15.55 K   32.65% 0.04%
SIMPLEX TRADING, LLC 02/11/2026 7.99 K $12.46 K   -36.13% 0.03%
DEUTSCHE BANK AG\ 02/11/2026 6.92 K $10.80 K   -88.78% 0.03%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 6.60 K $10.30 K   68.52% 0.02%
TOWER RESEARCH CAPITAL LLC (TRC) 02/17/2026 5.91 K $9.22 K   -10.48% 0.02%
NEWEDGE ADVISORS, LLC 02/18/2026 5.00 K $7.80 K   0.00% 0.02%
MAI CAPITAL MANAGEMENT 02/13/2026 4.48 K $6.98 K   -42.58% 0.02%

INmune Bio Inc institutional Ownership - FAQ's

During the previous two years, 100 institutional investors and hedge funds held shares of INmune Bio Inc. The most heavily invested institutionals were:

UBS Group AG: 253,340

VANGUARD FIDUCIARY TRUST CO: 123,184

Westside Investment Management, Inc.: 108,300

Bank of New York Mellon Corp: 53,628

JANE STREET GROUP, LLC: 50,944

PNC FINANCIAL SERVICES GROUP, INC.: 40,120

19.12% of INmune Bio Inc stock is owned by institutional investors.

Institutional investors have bought a total of 7.27 M shares in the last 24 months. This purchase volume represents approximately $9.53 M in transactions.